1Phua J, Koay ES, Lee KH. Lactate, procalcitonin, and amino- terminal pro-B-type natriuretie peptide versus cytokine measurements and clinical severity scores for prognostication in septic shock[J]. Shock,2008,29(3) :328-333.
5Jongwutiwes U, Suitharak K, Tiengrim S, et al. Serum procalcitonin in diagnosis of baeteremia[J]. J Med Assoe Thai, 2009,92(Suppl 2) :S79-87.
6Tseng JS,Chan MC, Hsu JY, et al. Procalcitonin is a valuable prognoslie marker in ARDS caused by community-acquired pneumonia[J]. Respirology, 2008,13 (4) :505-509.
7Barati M, Alinejad F, Bahar MA, et al. Comparison of WBC, ESR,CRP and PCT serum levels in septic and non-septic burn cases[J]. Burns,2008,34(6) : 770-774.
2Lin S H, Kuo P H, Hsueh P R, et al. Sputum bacteriology in hospi- talized patients with acute exacerbation of chronic obstructive pul- monary disease in Taiwan with an emphasis on Klebsiella pneumo- nia and Pseudomonas aeruginosa[ J ]. Respirology, 2007,12 (1) :81 - 87.
3Guven H, Altintop L, Baydin A, et al. Diagnostic value procalito- nin levels as an early indicator of sepsis [ J ]. Amj Emeg Med, 2002,20:202 - 206.
4Hohn A, Sehroeder S, Gehrt A, et al. Procalcitoni n-guided algo- rithm to reduce length of antibiotic therapy in patients with severe sepsis and septic shock[J]. BMC Infectious Diseases, 2013 13: 158.
5Rammaert B, Verdier N, Cavestri B, et al. Procalcitonin as a prog- nostic factor in severeacute exacerbationof chronic obstructive pul- monary disease[ J]. Respirology ,2009,14:969 - 974.
6Knaus WA, Draper EA, Wagner DP, et al. APACHE Ⅱ : a severity of disease classification system [ J ]. Crit Care Med, 1985,13 (10) : 818 -829.
7Daniels JM, Schoorl M, Snijders D. et al. Procalcitonin vs Creactive protein as predictive markers of response to antibiotic therapy in a- cute exacerbations of COPD[ J]. Chest,2010,138 (5) : 1108 - 15.
8Lacoma A, Prat C, Andreo F, et al. Value of procalcitonin, C-reac- tive protein, and neopterin in exacerbations of chronic obstructive pulmonary disease [ J ]. International Journal of COPD, 2011,6 : 157 -69.